besides ABC transporters themselves, the vesicles in which they reside, the lipid raft microdomains in which they are organized and oligomerized as well as the cytoskeleton are new potential drug targets.
No takes yet. Share an insight, caveat, or question.
Stefan et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: